My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    The unresolved safety concerns of bovine thrombin.

    Shander A, Javidroozi M.

    Patient Saf Surg. 2008 Sep 22;2:23.PMID: 18808708 [PubMed - in process]Related articlesFree article

    2.

    Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature.

    Reynolds MW, Clark J, Crean S, Samudrala S.

    Patient Saf Surg. 2008 Mar 18;2:5.PMID: 18348725 [PubMed - in process]Related articlesFree article

    3.

    A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.

    Ofosu FA, Crean S, Reynolds MW.

    Clin Ther. 2009 Apr;31(4):679-91. Review.PMID: 19446142 [PubMed - indexed for MEDLINE]Related articles

    4.

    A review of three stand-alone topical thrombins for surgical hemostasis.

    Cheng CM, Meyer-Massetti C, Kayser SR.

    Clin Ther. 2009 Jan;31(1):32-41. Review.PMID: 19243705 [PubMed - indexed for MEDLINE]Related articles

    5.

    Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.

    Ness P, Creer M, Rodgers GM, Naoum JJ, Renkens K, Voils SA, Alexander WA; the Recognition, Evaluation and Treatment of Acquired Coagulopathy Consensus (RETACC) Panel.

    Patient Saf Surg. 2009 May 22;3(1):8.PMID: 19463180 [PubMed - as supplied by publisher]Related articlesFree article

    6.

    Recent developments in topical thrombins.

    Kessler CM, Ortel TL.

    Thromb Haemost. 2009 Jul;102(1):15-24. Review.PMID: 19572062 [PubMed - indexed for MEDLINE]Related articles

    7.

    The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.

    Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N.

    Health Technol Assess. 2009 Jun;13(31):iii-iv, ix-xi, 1-77. Review.PMID: 19573471 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Safety of topical thrombins: the ongoing debate.

    Lomax C.

    Patient Saf Surg. 2009 Sep 4;3(1):21.PMID: 19732447 [PubMed - in process]Related articlesFree article

    9.

    Acquired coagulation factor inhibitors in children after topical bovine thrombin exposure.

    Savage WJ, Kickler TS, Takemoto CM.

    Pediatr Blood Cancer. 2007 Dec;49(7):1025-9.PMID: 16526049 [PubMed - indexed for MEDLINE]Related articles

    10.

    Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.

    Merli G, Spyropoulos AC, Caprini JA.

    Ann Surg. 2009 Aug;250(2):219-28. Review.PMID: 19638915 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical use of topical thrombin as a surgical hemostat.

    Lew WK, Weaver FA.

    Biologics. 2008 Dec;2(4):593-9.PMID: 19707440 [PubMed - in process]Related articlesFree article

    12.

    Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

    Cziraky MJ, Watson KE, Talbert RL.

    J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.PMID: 19891279 [PubMed - indexed for MEDLINE]Related articles

    13.

    Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study.

    Birth M, Figueras J, Bernardini S, Troen T, Günther K, Mirza D, Mortensen FV.

    Patient Saf Surg. 2009 Jun 22;3(1):13.PMID: 19545437 [PubMed - in process]Related articlesFree article

    14.

    Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.

    Tuccori M, Lapi F, Testi A, Coli D, Moretti U, Vannacci A, Motola D, Salvo F, Rivolta AL, Blandizzi C, Mugelli A, Del Tacca M.

    Drug Saf. 2008;31(12):1115-23. doi: 10.2165/0002018-200831120-00007.PMID: 19026028 [PubMed - indexed for MEDLINE]Related articles

    15.

    Topical thrombins: benefits and risks.

    Lomax C, Traub O.

    Pharmacotherapy. 2009 Jul;29(7 Pt 2):8S-12S.PMID: 19558279 [PubMed - indexed for MEDLINE]Related articles

    16.

    Topical use of recombinant human thrombin for operative hemostasis.

    Anderson CD, Bowman LJ, Chapman WC.

    Expert Opin Biol Ther. 2009 Jan;9(1):133-7. Review.PMID: 19063699 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

    Baetz BE, Spinler SA.

    Pharmacotherapy. 2008 Nov;28(11):1354-73. Review.PMID: 18956996 [PubMed - indexed for MEDLINE]Related articles

    18.

    Acquired factor V inhibitor. A problem-based systematic review.

    Ang AL, Kuperan P, Ng CH, Ng HJ.

    Thromb Haemost. 2009 May;101(5):852-9. Review.PMID: 19404538 [PubMed - indexed for MEDLINE]Related articles

    19.

    Immune-mediated coagulopathy: a case report.

    Naoum JJ.

    Pharmacotherapy. 2009 Jul;29(7 Pt 2):13S-7S.PMID: 19558280 [PubMed - indexed for MEDLINE]Related articles

    20.

    Antihuman factor V antibodies after use of relatively pure bovine thrombin.

    Lawson JH, Lynn KA, Vanmatre RM, Domzalski T, Klemp KF, Ortel TL, Niklason LE, Parker W.

    Ann Thorac Surg. 2005 Mar;79(3):1037-8.PMID: 15734434 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk